Retraction Note To: SOX2 Oncogenes Amplified and Operate to Activate AKT Signalling in Gastric Cancer and Predict Immunotherapy Responsiveness

Journal of Cancer Research and Clinical Oncology - Germany
doi 10.1007/s00432-019-02878-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Retraction: MicroRNA-371-5p Targets SOX2 in Gastric Cancer

Oncotarget
Oncology
2018English

The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Retraction Note To: Retraction Notice

Cell Research
Cell BiologyMolecular Biology
2005English

Retraction Note To: KDM3A Confers Metastasis and Chemoresistance in Epithelial Ovarian Cancer

Journal of Molecular Histology
MedicineCell BiologyHistologyPhysiology
2016English

Fibroblastic Reticular Cells Predict Response to Cancer Immunotherapy

2020English

Gastric Cancer Immunotherapy

Russian Journal of Biotherapy
2019English

AKT Signaling in ERBB2-amplified Breast Cancer

Pharmacology and Therapeutics
Pharmacology
2016English

MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis

PLoS ONE
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy